AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9737826 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 7586929 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate 2400 mg/day
Number of subjects: 18
Study 7586929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: High potency (HP) extract (300 micrograms AgE)
Number of subjects: 0
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: Low potency (LP) extracts
Number of subjects: 0
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: High potency (HP) extract (9-dose regimen)
Number of subjects: 0
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: Low potency (LP) extract
Number of subjects: 0
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: High potency (HP) extract
Number of subjects: 0
Study 2252164 — intervention group
Group type: EXPERIMENTAL
Intervention: High potency (HP) and Low potency (LP) extracts
Number of subjects: 0
Study 6118758 — intervention group
Group type: EXPERIMENTAL
Intervention: dl‐propranolol (640 mg/day)
Number of subjects: 0
Study 6118758 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐propranolol (640 mg/day)
Number of subjects: 0
Study 30785645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with common bile duct stone (CBDS)
Number of subjects: 1044
Study 30785645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with biliary stricture (BS)
Number of subjects: 1044
Study 30785645 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulation by trainees in patients with other indications
Number of subjects: 1044
Study 30785645 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of type A diverticulum
Number of subjects: 1044
Study 30785645 — intervention group
Group type: EXPERIMENTAL
Intervention: Indication of biliary stricture (BS)
Number of subjects: 1044
Study 30785645 — intervention group
Group type: COMPARATOR
Intervention: Biliary infection in BS vs CBDS
Number of subjects: 1044
Study 28187138 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaze training intervention (QET)
Number of subjects: 21
Study 28187138 — intervention group
Group type: COMPARATOR
Intervention: Technical training (TT)
Number of subjects: 21
Study 26329472 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led healthy lifestyle intervention (derived from the Group Lifestyle Balanced Program, lasting 12 months, delivered by trained peer specialists)
Number of subjects: 0
Study 26329472 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 24187119 — intervention group
Group type: EXPERIMENTAL
Intervention: Community doula home visiting intervention
Number of subjects: 248
Study 20652630 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session HIV/HCV counseling and education (C&E) model added to treatment as usual (TAU)
Number of subjects: 632
Study 20652630 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session therapeutic alliance (TA) intervention conducted by outpatient counselors to facilitate treatment entry plus TAU
Number of subjects: 632
Study 20652630 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 632
Study 19649583 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,5-pentanediol (PD) gel
Number of subjects: 105
Study 19649583 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 105
Study 17370492 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple puncture at Tianzong (SI 11) combined with local points of the elbow
Number of subjects: 62
Study 17370492 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture (local points of the elbow)
Number of subjects: 62
Study 15508669 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-trained participants using the Philips FR2
Number of subjects: 256
Study 15508669 — intervention group
Group type: COMPARATOR
Intervention: Naive participants using the Philips FR2
Number of subjects: 256
Study 15508669 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-trained participants using the HS1
Number of subjects: 256
Study 15508669 — intervention group
Group type: COMPARATOR
Intervention: Naive participants using the HS1
Number of subjects: 256
Study 11167372 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 microg, twice daily)
Number of subjects: 46
Study 11167372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 9771300 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous extradural infusion of 0.125% bupivacaine 12.5 mg h‐1 and morphine 0.25 mg h‐1 (EXI group)
Number of subjects: 60
Study 9771300 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with intravenous morphine (1 mg bolus, 5‐min lock‐out and maximum dose 20 mg 4h‐1)
Number of subjects: 60
Study 7870743 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 0
Study 7870743 — intervention group
Group type: EXPERIMENTAL
Intervention: WS 1490 (Kava-extract)
Number of subjects: 0
Study 2246759 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine added to metoclopramide regimen
Number of subjects: 27
Study 2246759 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine added to metoclopramide regimen
Number of subjects: 27
Study 44671 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary metoprolol tablets 0.1 g b.i.d.
Number of subjects: 16
Study 44671 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol slow-release tablets (Durules) 0.2 g once daily
Number of subjects: 16
Study 44671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 44671 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol slow-release tablets (Durules)
Number of subjects: 16
Study 44671 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary metoprolol tablets
Number of subjects: 16
Study 30209645 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based information communication technology early intervention application
Number of subjects: 59
Study 30209645 — intervention group
Group type: COMPARATOR
Intervention: Therapy-as-usual
Number of subjects: 59
Study 30209645 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants pooled
Number of subjects: 59
Study 28750975 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 1 second
Number of subjects: 32
Study 28750975 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 2 seconds
Number of subjects: 32
Study 28750975 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 3 seconds
Number of subjects: 32
Study 28750975 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-trial intervals (ITI) of 4 seconds
Number of subjects: 32
Study 26242767 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (Xultophy®)
Number of subjects: 0
Study 22549086 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical myostimulation (EMS)
Number of subjects: 19
Study 22549086 — intervention group
Group type: COMPARATOR
Intervention: Passive rest (PR)
Number of subjects: 19
Study 20938195 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonverbal auditory training for 2 months
Number of subjects: 40
Study 20938195 — intervention group
Group type: COMPARATOR
Intervention: Untrained dyslexic subjects (control group)
Number of subjects: 40
Study 19299356 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mitchell's osteotomy
Number of subjects: 60
Study 19299356 — intervention group
Group type: COMPARATOR
Intervention: Original Mitchell method
Number of subjects: 60
Study 17227978 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 6 cycles of gemcitabine on days 1, 8, and 15 every 4 weeks (n = 179)
Number of subjects: 368
Study 17227978 — intervention group
Group type: COMPARATOR
Intervention: Observation (control) (n = 175)
Number of subjects: 368
Study 17227978 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine
Number of subjects: 368
Study 17227978 — intervention group
Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 368
Study 15472185 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1200 mg calcium carbonate)
Number of subjects: 102
Study 15472185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 11216769 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine pericardial strips as a buttress along the lung staple line
Number of subjects: 80
Study 11216769 — intervention group
Group type: COMPARATOR
Intervention: Nonbuttressed staple line
Number of subjects: 80
Study 11216769 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonbuttressed)
Number of subjects: 80
Study 11216769 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (buttressed vs nonbuttressed)
Number of subjects: 80
Study 7889010 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (BMT) from HLA-identical sibling
Number of subjects: 69
Study 7889010 — intervention group
Group type: COMPARATOR
Intervention: Auto-BMT
Number of subjects: 69
Study 7889010 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 69
Study 7889010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antileukaemic therapy (vincristine, prednisone, daunorubicin, cyclophosphamide, Ara C, asparaginase)
Number of subjects: 69
Study 7889010 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 69
Study 3605674 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal morphine (0.5 mg/ml, 0.1 mg/kg)
Number of subjects: 46
Study 3605674 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine (0.25%, 1 ml/kg)
Number of subjects: 46
Study 3605674 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (control group)
Number of subjects: 46
Study 29720489 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive postacute stroke intervention
Number of subjects: 40
Study 29720489 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study 27306892 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry powder (2 or 4 servings)
Number of subjects: 23
Study 27306892 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 23
Study 27306892 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately high-fat breakfast (MHF)
Number of subjects: 23
Study 25917552 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope Cobalt Video laryngoscope
Number of subjects: 60
Study 25917552 — intervention group
Group type: COMPARATOR
Intervention: Flexible fiberoptic bronchoscope
Number of subjects: 60
Study 23129544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) ablation
Number of subjects: 60
Study 23129544 — intervention group
Group type: COMPARATOR
Intervention: Low-dose (LD) ablation
Number of subjects: 60
Study 21959624 — intervention group
Group type: EXPERIMENTAL
Intervention: OxyContin (Oxycodone) injections
Number of subjects: 90
Study 21959624 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexacort (Dexamethasone)
Number of subjects: 90
Study 21959624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 18248104 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% calorie restriction
Number of subjects: 48
Study 18248104 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5% calorie restriction and 12.5% increased energy expenditure by structured exercise
Number of subjects: 48
Study 18248104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet
Number of subjects: 48
Study 18248104 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet (no-calorie restriction)
Number of subjects: 48
Study 16785214 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone treatment
Number of subjects: 12
Study 16785214 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 12
Study 16785214 — intervention group
Group type: COMPARATOR
Intervention: Control of craving
Number of subjects: 12
Study 12592328 — intervention group
Group type: EXPERIMENTAL
Intervention: HuM195 at a dose of 12 mg/m(2)
Number of subjects: 50
Study 12592328 — intervention group
Group type: EXPERIMENTAL
Intervention: HuM195 at a dose of 36 mg/m(2)
Number of subjects: 50
Study 12592328 — intervention group
Group type: EXPERIMENTAL
Intervention: HuM195 (both doses)
Number of subjects: 50
Study 10962963 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralised lignocaine-epinephrine (1%, 5 microgram/ml) with 1.0 ml sodium bicarbonate (8.4 g/l) added to 10 ml lignocaine-epinephrine
Number of subjects: 0
Study 10962963 — intervention group
Group type: COMPARATOR
Intervention: Commercially available lignocaine-epinephrine (pH 4.7)
Number of subjects: 0
Study 24394578 — intervention group
Group type: EXPERIMENTAL
Intervention: 60mg iron, 500mg folic acid, 20,000 IU vitamin A, and 60mg vitamin C weekly for 5 weeks
Number of subjects: 84
Study 24394578 — intervention group
Group type: COMPARATOR
Intervention: 60mg iron and 250mg folic acid weekly for 5 weeks
Number of subjects: 84
Study 1335440 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg)
Number of subjects: 10
Study 1335440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6464191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oltipraz 1 X 25 mg/kg body weight
Number of subjects: 165
Study 6464191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oltipraz 1 X 35 mg/kg body weight
Number of subjects: 165
Study 6464191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oltipraz 2 X 20 mg/kg body weight
Number of subjects: 165
Study 6464191 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel 2 X 30 mg/kg body weight
Number of subjects: 165
Study 6464191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oltipraz
Number of subjects: 165
Study 6464191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 165
Study 30718072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg) plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Number of subjects: 645
Study 30718072 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cisplatin (80 mg/m2) and capecitabine (1000 mg/m2, twice daily for 14 days) every 21 days.
Number of subjects: 645
Study 30718072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg) plus cisplatin and capecitabine.
Number of subjects: 645
Study 30718072 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus cisplatin and capecitabine.
Number of subjects: 645
Study 29935884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) for 10 weeks (n=25)
Number of subjects: 49
Study 29935884 — intervention group
Group type: COMPARATOR
Intervention: Computer Game (CG) control for 10 weeks (n=24)
Number of subjects: 49
Study 27131832 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% menthol
Number of subjects: 0
Study 27131832 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol (various concentrations: 0.04%, 0.4%, 1%, 2%, 4%, 7%, 8%)
Number of subjects: 0
Study 27131832 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol during PORH
Number of subjects: 0
Study 27131832 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol during local heating
Number of subjects: 0
Study 27131832 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol with sensory nerve inhibition
Number of subjects: 0
Study 27131832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24947447 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol consumption advice plus an information leaflet
Number of subjects: 1709
Study 24947447 — intervention group
Group type: COMPARATOR
Intervention: Information leaflet alone
Number of subjects: 1709
Study 21744028 — intervention group
Group type: COMPARATOR
Intervention: Dried cassava leaves at 0%, 20%, 40%, and 60% inclusion levels in diets
Number of subjects: 40
Study 19951443 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (reminder plus provider recommendation to call the Cancer Information Service and sample questions to ask)
Number of subjects: 0
Study 19951443 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (routine colposcopy reminder letter)
Number of subjects: 0
Study 17825001 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study 17825001 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 15775795 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril 20 mg once daily
Number of subjects: 64
Study 15775795 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg once daily
Number of subjects: 64
Study 15775795 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 12.5 mg once daily
Number of subjects: 64
Study 15775795 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine and Chlorthalidone compared to Benazepril
Number of subjects: 64
Study 12175274 — intervention group
Group type: COMPARATOR
Intervention: PNCRM7 (PrevnarTM1) vaccine
Number of subjects: 211565
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Tense category music
Number of subjects: 12
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed category music
Number of subjects: 12
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry category music
Number of subjects: 12
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: All moods category music
Number of subjects: 12
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance music
Number of subjects: 12
Study 10067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Popular/independent music (associated with tense category)
Number of subjects: 12
Study 7499013 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 41
Study 7499013 — intervention group
Group type: COMPARATOR
Intervention: External landmark technique
Number of subjects: 41
Study 2207950 — intervention group
Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with weekly homework, interim weigh-ins, and participation deposits
Number of subjects: 142
Study 2207950 — intervention group
Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with both homework and interim weigh-ins
Number of subjects: 142
Study 2207950 — intervention group
Group type: COMPARATOR
Intervention: Correspondence weight control program
Number of subjects: 142
Study 2207950 — intervention group
Group type: EXPERIMENTAL
Intervention: Correspondence weight control program with both homework and weigh-ins
Number of subjects: 142
Study 344085 — intervention group
Group type: EXPERIMENTAL
Intervention: Trancopal 400 mg
Number of subjects: 68
Study 344085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 30790095 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 2350
Study 28511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception supplements containing Folic Acid, Iron and Folic Acid (IFA), or Multiple Micronutrients
Number of subjects: 5011
Study 28511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal IFA supplements for daily consumption through delivery
Number of subjects: 5011
Study 28511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception supplements
Number of subjects: 5011
Study 28511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal adherence
Number of subjects: 5011
Study 28511688 — intervention group
Group type: EXPERIMENTAL
Intervention: Village health worker visits
Number of subjects: 5011
Study 26856014 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental 1450 ppm fluoride as sodium monofluorophosphate (SMFP)/zinc‐based dentifrice
Number of subjects: 14
Study 26856014 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically proven 1450 ppm fluoride as SMFP/zinc‐based dentifrice (Positive Control)
Number of subjects: 14
Study 26856014 — intervention group
Group type: COMPARATOR
Intervention: 1000 ppm fluoride as SMFP and 450 ppm fluoride as sodium fluoride (NaF) dentifrice (Negative Control)
Number of subjects: 14
Study 23852814 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 9
Study 21804439 — intervention group
Group type: COMPARATOR
Intervention: Manufacturers' guidelines (cases rinsed with multipurpose solution and air dried)
Number of subjects: 40
Study 21804439 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative cleaning regimen (cases rubbed, rinsed with solution, tissue wiped, and air-dried face down)
Number of subjects: 40
Study 19197204 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage (40-minute myofascial induction)
Number of subjects: 60
Study 19197204 — intervention group
Group type: COMPARATOR
Intervention: Placebo (40-minute sham electrotherapy)
Number of subjects: 60
Study 19197204 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Massage and Placebo)
Number of subjects: 60
Study 19197204 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 60
Study 17178974 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (30 to 60 mg per day)
Number of subjects: 21
Study 14644598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose membrane dressing (group 1)
Number of subjects: 3
Study 14644598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose membrane dressing (group 3)
Number of subjects: 3
Study 14644598 — intervention group
Group type: COMPARATOR
Intervention: Unna boot (group 2)
Number of subjects: 3
Study 11237488 — intervention group
Group type: COMPARATOR
Intervention: 5-day drainage
Number of subjects: 121
Study 11237488 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-day drainage
Number of subjects: 121
Study 9564200 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole 24 mg/day
Number of subjects: 282
Study 9564200 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol 10 mg/day
Number of subjects: 282
Study 8064705 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release, 10-mg pessary
Number of subjects: 0
Study 8064705 — intervention group
Group type: COMPARATOR
Intervention: Low-dose gel, 2.5-mg doses
Number of subjects: 0